Stay updated on Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page.

Latest updates to the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page
- Check4 days agoChange DetectedThe page revision changed from v3.6.4 to v3.6.5, indicating a new version of the page has been deployed. This reflects version control activity rather than substantive content changes to the study details.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA new revision label v3.6.4 was added and the prior v3.6.3 revision was removed.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe revision tag on the page was updated from v3.6.2 to v3.6.3, indicating a new version of the page materials. This reflects a minor update to the page's documentation or release notes rather than content changes.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page's revision label changed from v3.6.0 to v3.6.2, indicating a new version of the page has been released. This reflects a deployment update rather than a substantive change to study content or functionality.SummaryDifference0.0%

- Check61 days agoChange DetectedRecruitment status is updated to indicate no longer looking for participants, and new guidance sections such as How to Read a Study Record, Common Questions, and How to Join a Study have been added; the Intervention/Treatment header has been reformatted for consistency.SummaryDifference0.2%

- Check68 days agoChange DetectedThe page revision was bumped from v3.5.4 to v3.5.5 as a minor maintenance update. This does not alter the study details or other user-facing content.SummaryDifference0.0%

Stay in the know with updates to Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page.